MiR-221 could be responsible for tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) resistance in breast cancer cells by regulating PTEN, thus inducing EMT and increasing migration and invasiveness of breast cancer cells. Here, PTEN is linked to breast carcinoma.